Viewing Study NCT00004296



Ignite Creation Date: 2024-05-05 @ 9:36 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004296
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-10-18

Brief Title: Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
Sponsor: National Center for Research Resources NCRR
Organization: Office of Rare Diseases ORD

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2000-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES I Determine the prevalence of nontuberculous mycobacteria in sputum cultures from patients with cystic fibrosis

II Compare the clinical course of patients with negative versus positive cultures
Detailed Description: PROTOCOL OUTLINE Participants are screened for nontuberculous mycobacteria NTM with 3 sputum acid-fast bacilli smears and mycobacterial cultures with speciation of positive cultures collected over 1 year Demographic data diagnostic criteria clinical measurements and other respiratory pathogen data are collected using the Cystic Fibrosis Foundation Patient Registry Questionnaire

NTM-positive patients cases matched with NTM-negative controls identified in screening are followed every 3 months for 15 months Cases are evaluated for NTM burden during the first 3 months

Appropriate therapy is offered to consistently NTM-positive cases Lung transplant recipients are removed from study

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
UNCCH-939 None None None